Halozyme Therapeutics, Inc. (HALO)
64.95
-0.41
(-0.63%)
USD |
NASDAQ |
Apr 27, 14:11
Halozyme Therapeutics Price : 64.95 for April 27, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vertex Pharmaceuticals, Inc. | 428.79 |
| Johnson & Johnson | 225.62 |
| Eli Lilly & Co. | 877.85 |
| Baxter International, Inc. | 18.43 |
| Glaukos Corp. | 122.13 |
Price Related Metrics
| PE Ratio | 26.07 |
| PS Ratio | 5.706 |
| Price to Book Value | 157.03 |
| Price to Free Cash Flow | 12.36 |
| Earnings Yield | 3.84% |
| Market Cap | 7.665B |
| Operating PE Ratio | 9.763 |
| Normalized PE Ratio | 14.15 |